Related Experiment Video
Updated: Dec 19, 2025

In Vitro Model of Coronary Angiogenesis
Published on: March 10, 2020
The interaction of lead exposure and CCM3 defect plays an important role in regulating angiogenesis through eNOS/NO
Yi Sun1, Zhiqiang Zhao2, Haifeng Zhang3
1Department of Health Toxicology, Sun Yat-sen University School of Public Health, Guangzhou, Guangdong, 510080, China; Department of Environmental Health and Occupational Medicine, Guilin Medical University School of Public Health, Guilin, Guangxi, 541004, China.
Abstract:
In this study, we aimed to explore the role of nitric oxide (NO) in regulating angiogenesis in cerebral cavernous malformations 3 gene (CCM3)-deficient mice exposed to lead during vascular development; further, we aimed to identify and study the potential mechanism involved as well. Angiogenesis was detected by whole mount immunofluorescent staining of retinal vessels in WT and CCM3+/- mice. Brain microvascular endothelial cells (BMECs) isolated from WT and CCM3+/- mice, primary HUVECs, and immortalized HUVECs (imHUVECs) (CCM3+/+ and CCM3-/-) were used and treated with lead acetate (PbAc). RT-PCR and Western blotting were used to detect the mRNA and protein expression of iNOS, eNOS, and VEGF genes. The results showed that both lead exposure and CCM3 gene deficiency adversely affected endothelial cell function, causing abnormal angiogenesis and vascular remodeling. The mRNA expression of eNOS and iNOS was significantly different in WT and CCM3+/- BMECs (0.04 ± 0.001 vs. 0.016 ± 0.002; 0.26 ± 0.002 vs. 0.306 ± 0.002, respectively), and the expression of eNOS and iNOS in imHUVECs (CCM3+/+ and CCM3-/-) also increased after PbAc exposure. In conclusion, CCM3 gene-deficient mice were more susceptible to abnormal vascular development after low-level lead exposure, probably due to the release of NO.
Insights
Cerebral cavernous malformation 3 (CCM3) gene deficiency increases susceptibility to lead-induced abnormal vascular development. Nitric oxide (NO) release likely mediates these adverse effects on angiogenesis.
Area of Science:
- Vascular biology
- Toxicology
- Developmental biology
Background:
- Cerebral cavernous malformations (CCMs) are vascular abnormalities.
- CCM3 gene is crucial for vascular development.
- Lead exposure can disrupt vascular integrity.
Purpose of the Study:
- Investigate nitric oxide (NO) role in CCM3 deficiency-induced angiogenesis.
- Examine lead acetate (PbAc) effects on vascular development.
- Elucidate the underlying molecular mechanisms.
Main Methods:
- Whole mount immunofluorescent staining of retinal vessels in wild-type (WT) and CCM3+/- mice.
- Isolation and treatment of brain microvascular endothelial cells (BMECs), HUVECs, and immortalized HUVECs (imHUVECs) with PbAc.
- RT-PCR and Western blotting to analyze iNOS, eNOS, and VEGF gene expression.
Main Results:
- Lead exposure and CCM3 deficiency impaired endothelial cell function, leading to abnormal angiogenesis and vascular remodeling.
- Significant differences in eNOS and iNOS mRNA expression were observed in WT and CCM3+/- BMECs.
- PbAc exposure increased eNOS and iNOS expression in imHUVECs (CCM3+/+ and CCM3-/-).
Conclusions:
- CCM3 gene deficiency exacerbates lead-induced abnormal vascular development.
- Nitric oxide (NO) release is implicated in the adverse effects of lead on angiogenesis in CCM3-deficient models.
- These findings highlight the critical role of CCM3 in vascular health and response to environmental toxins.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway

